Pulse Biosciences Inc (NASDAQ: PLSE) is 66.42% higher on its value in year-to-date trading and has touched a low of $6.59 and a high of $22.69 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The PLSE stock was last observed hovering at around $20.30 in the last trading session, with the day’s gains setting it 0.07%.
Currently trading at $20.37, the stock is 16.62% and 18.42% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.18 million and changing 0.34% at the moment leaves the stock 50.81% off its SMA200. PLSE registered 133.07% gain for a year compared to 6-month gain of 69.05%. The firm has a 50-day simple moving average (SMA 50) of $17.1736 and a 200-day simple moving average (SMA200) of $13.44415.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 19.54% loss in the last 1 month and extending the period to 3 months gives it a 5.71%, and is 26.21% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.24% over the week and 9.33% over the month.
Pulse Biosciences Inc (PLSE) has around 56 employees, a market worth around $1.25B and $0.00M in sales. Distance from 52-week low is 208.87% and -10.22% from its 52-week high. The company has generated returns on investments over the last 12 months (-53.45%).
114.0 institutions hold shares in Pulse Biosciences Inc (PLSE), with institutional investors hold 33.14% of the company’s shares. The shares outstanding are 55.14M, and float is at 17.10M with Short Float at 12.19%. Institutions hold 9.30% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 1.15 million shares valued at $12.83 million. The investor’s holdings represent 2.0787 of the PLSE Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.91 million shares valued at $10.13 million to account for 1.641 of the shares outstanding. The other top investors are BANK OF AMERICA CORP /DE/ which holds 0.78 million shares representing 1.4184 and valued at over $8.76 million, while GEODE CAPITAL MANAGEMENT, LLC holds 0.7684 of the shares totaling 0.42 million with a market value of $4.75 million.
Pulse Biosciences Inc (PLSE) Insider Activity
The most recent transaction is an insider purchase by Barrett Burke Thomas, the company’s President and CEO. SEC filings show that Barrett Burke Thomas bought 10,000 shares of the company’s common stock on May 20 ’24 at a price of $8.56 per share for a total of $85600.0. Following the purchase, the insider now owns 10000.0 shares.
Pulse Biosciences Inc disclosed in a document filed with the SEC on Dec 12 ’23 that DUGGAN ROBERT W (Director) bought a total of 17,999 shares of the company’s common stock. The trade occurred on Dec 12 ’23 and was made at $9.15 per share for $0.16 million. Following the transaction, the insider now directly holds 36.98 million shares of the PLSE stock.
Still, SEC filings show that on Dec 11 ’23, DUGGAN ROBERT W (Director) acquired 90,118 shares at an average price of $9.36 for $0.84 million. The insider now directly holds 36,966,180 shares of Pulse Biosciences Inc (PLSE).